Nuclear receptors have distinct affinities for coactivators: Characterization by fluorescence resonance energy transfer

被引:151
作者
Zhou, GC
Cummings, R
Li, Y
Mitra, S
Wilkinson, HA
Elbrecht, A
Hermes, JD
Schaeffer, JM
Smith, RG
Moller, DE
机构
[1] Merck Res Labs, Dept Biochem & Physiol, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Mol Design & Divers, Rahway, NJ 07065 USA
关键词
D O I
10.1210/me.12.10.1594
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ligand-dependent interactions between nuclear receptors and members of a family of nuclear receptor coactivators are associated with transcriptional activation. Here we used fluorescence resonance energy transfer (FRET) as an approach for detecting and quantitating such interactions. Using the ligand binding domain (LBD) of peroxisome proliferator-activated receptor (PPAR gamma) as a model, known agonists (thiazolidinediones and Delta 12, 14-PGJ2) induced a specific interaction resulting in FRET between the fluorescently labeled LBD and fluorescently labeled coactivators [CREB-binding protein (CBP) or steroid receptor coactivator-1 (SRC-1)]. Specific energy transfer was dose dependent; individual ligands displayed distinct potency and maximal FRET profiles that were identical when results obtained using CBP vs. SRC-1 were compared. In addition, half-maximally effective agonist concentrations (EC(50)s) correlated well with reported results using cell-based assays. A site-directed AF2 mutant of PPAR gamma (E471A) that abrogated ligand-stimulated transcription in transfected cells also failed to induce ligand-mediated FRET between PPAR gamma LBD and CBP or SRC-1. Using estrogen receptor (ER alpha) as an alternative system, known agonists induced an interaction between ER alpha LBD and SRC-1, whereas ER antagonists disrupted agonist-induced interaction of ER alpha with SRC-1. In the presence of saturating agonist concentrations, unlabeled CBP or SRC-1 was used to compete with fluorescently labeled coactivators with saturation kinetics. Relative affinities for the individual receptor-coactivator pairs were determined as follows: PPAR gamma-CBP = ER alpha-SRC-1 > PPAR gamma-SRC-1 much greater than ER alpha-CBP. Conclusions: 1) FRET-based coactivator association is a novel approach for characterizing nuclear receptor agonists or antagonists; individual ligands display potencies that are predictive of in vivo effects and distinct profiles of maximal activity that are suggestive of alternative receptor conformations. 2) PPAR gamma interacts with both CBP and SRC-1; transcriptional activation and coactivator association are AF2 dependent. 3) Nuclear receptor LBDs have distinct affinities for individual coactivators; thus, PPAR gamma has a greater apparent affinity for CBP than for SRC-1, whereas ER alpha interacts preferentially with SRC-1 but very weakly with CBP.
引用
收藏
页码:1594 / 1604
页数:11
相关论文
共 43 条
  • [21] Differential use of CREB binding protein coactivator complexes
    Kurokawa, R
    Kalafus, D
    Ogliastro, MH
    Kioussi, C
    Xu, L
    Torchia, J
    Rosenfeld, MG
    Glass, CK
    [J]. SCIENCE, 1998, 279 (5351) : 700 - 703
  • [22] NUCLEAR-PROTEIN CBP IS A COACTIVATOR FOR THE TRANSCRIPTION FACTOR CREB
    KWOK, RPS
    LUNDBLAD, JR
    CHRIVIA, JC
    RICHARDS, JP
    BACHINGER, HP
    BRENNAN, RG
    ROBERTS, SGE
    GREEN, MR
    GOODMAN, RH
    [J]. NATURE, 1994, 370 (6486) : 223 - 226
  • [23] INSULIN-MIMETIC AND INSULIN-SENSITIZING DRUGS
    LEBOVITZ, HE
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1993, 20 (02) : 89 - 91
  • [24] AN ANTIDIABETIC THIAZOLIDINEDIONE IS A HIGH-AFFINITY LIGAND FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA(PPAR-GAMMA)
    LEHMANN, JM
    MOORE, LB
    SMITHOLIVER, TA
    WILKISON, WO
    WILLSON, TM
    KLIEWER, SA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) : 12953 - 12956
  • [25] LIANG C, 1998, NATURE, V391, P82
  • [26] THE NUCLEAR RECEPTOR SUPERFAMILY - THE 2ND DECADE
    MANGELSDORF, DJ
    THUMMEL, C
    BEATO, M
    HERRLICH, P
    SCHUTZ, G
    UMESONO, K
    BLUMBERG, B
    KASTNER, P
    MARK, M
    CHAMBON, P
    EVANS, RM
    [J]. CELL, 1995, 83 (06) : 835 - 839
  • [27] MATHIS G, 1993, CLIN CHEM, V39, P1953
  • [28] ANALYSIS OF ESTROGEN-RECEPTOR FUNCTION IN-VITRO REVEALS 3 DISTINCT CLASSES OF ANTIESTROGENS
    MCDONNELL, DP
    CLEMM, DL
    HERMANN, T
    GOLDMAN, ME
    PIKE, JW
    [J]. MOLECULAR ENDOCRINOLOGY, 1995, 9 (06) : 659 - 669
  • [29] Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator
    McInerney, EM
    Tsai, MJ
    OMalley, BW
    Katzenellenbogen, BS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (19) : 10069 - 10073
  • [30] The transcriptional coactivators p300 and CBP are histone acetyltransferases
    Ogryzko, VV
    Schiltz, RL
    Russanova, V
    Howard, BH
    Nakatani, Y
    [J]. CELL, 1996, 87 (05) : 953 - 959